                         SEQUENCE LISTING

<110>  THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF
        ARIZONA
       Polt, Robin
       Heien, Michael
       Pemberton, Jeanne
 
<120>  NANOPARTICLE COMPOSITIONS AND METHODS FOR ENHANCED STABILITY AND 
       DELIVERY OF GLYCOPEPTIDE DRUGS

<130>  UA17-039 UNIA 16.40 PCT

<150>  US 62/373,309
<151>  2016-08-10

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycopeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-Alanine

<220>
<221>  CARBOHYD
<222>  (5)..(5)
<223>  Serine is beta-D-Glc

<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  AMIDATION (C-terminal amine)

<400>  1

Tyr Xaa Gly Phe Ser 
1               5   


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycopeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is D-Thr

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  AMIDATION  (C-terminal amine)

<220>
<221>  CARBOHYD
<222>  (6)..(6)
<223>  Ser(beta-Lact)

<400>  2

Tyr Xaa Gly Phe Leu Ser 
1               5       


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycopeptide


<220>
<221>  CARBOHYD
<222>  (7)..(7)
<223>  Ser(beta-D-Glc)

<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  AMIDATION (C-terminal amine)

<400>  3

Asp Arg Val Tyr Ile His Ser 
1               5           


<210>  4
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycopeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-thr

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  gamma amino butyric acid (GABA)

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Ser-beta-D-Glc

<220>
<221>  MOD_RES
<222>  (25)..(25)
<223>  AMIDATION (C-terminal amine)

<400>  4

Tyr Thr Gly Phe Leu Xaa Asn Leu Asx Glu Glu Glu Glu Glu Glu Glu 
1               5                   10                  15      


Glu Glu Glu Lys Ala Leu Lys Ser Leu 
            20                  25  


<210>  5
<211>  56
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Glycopeptide


<220>
<221>  MOD_RES
<222>  (56)..(56)
<223>  AMIDATION (C-terminal amine)

<220>
<221>  MISC_FEATURE
<222>  (56)..(56)
<223>  Ser-beta-lact

<400>  5

His Ser Asp Ala Val Phe Thr Asp Asn Tyr Tyr Tyr Tyr Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Thr Arg Leu Arg Lys Gln Leu Ala Val Lys Lys Lys Lys 
            20                  25                  30          


Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys Lys 
        35                  40                  45              


Lys Tyr Leu Asn Ser Ile Leu Ser 
    50                  55      


